Effect of secukinumab on clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial

British Journal of Dermatology, Volume 0, Issue ja, -Not available-.


https://ift.tt/2z6TZsR